FFACX
Price
$17.32
Change
+$0.04 (+0.23%)
Updated
Dec 3 closing price
Net Assets
2.86B
RIRAX
Price
$80.97
Change
+$0.41 (+0.51%)
Updated
Dec 3 closing price
Net Assets
120.93B
Interact to see
Advertisement

FFACX vs RIRAX

Header iconFFACX vs RIRAX Comparison
Open Charts FFACX vs RIRAXBanner chart's image
Franklin Global Allocation C
Price$17.32
Change+$0.04 (+0.23%)
VolumeN/A
Net Assets2.86B
American Funds Capital Income Bldr R1
Price$80.97
Change+$0.41 (+0.51%)
VolumeN/A
Net Assets120.93B
FFACX vs RIRAX Comparison Chart in %
View a ticker or compare two or three
VS
FFACX vs. RIRAX commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FFACX is a StrongBuy and RIRAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RIRAX has more cash in the bank: 121B vs. FFACX (2.86B). RIRAX pays higher dividends than FFACX: RIRAX (2.15) vs FFACX (0.37). FFACX was incepted earlier than RIRAX: FFACX (22 years) vs RIRAX (24 years). FFACX (1.77) is less costly to investors than RIRAX (1.36). FFACX is a more actively managed with annual turnover of: 59.82 vs. RIRAX (56.00). RIRAX has a lower initial minimum investment than FFACX: RIRAX (250) vs FFACX (1000). RIRAX annual gain was more profitable for investors over the last year : 12.78 vs. FFACX (9.15). RIRAX return over 5 years is better than : 41.81 vs. FFACX (35.91).
FFACXRIRAXFFACX / RIRAX
Total Expense Ratio1.741.36128%
Annual Report Gross Expense Ratio1.771.36130%
Fund Existence22 years24 years-
Gain YTD11.61818.18064%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets2.86B121B2%
Annual Yield % from dividends0.372.1517%
Returns for 1 year9.1512.7872%
Returns for 3 years35.7632.37110%
Returns for 5 years35.9141.8186%
Returns for 10 years51.9659.6887%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CBBIX6.96N/A
N/A
AB Relative Value I
SHSSX74.01N/A
N/A
BlackRock Health Sciences Opps Instl
VNVAX25.80N/A
N/A
Natixis Vaughan Nelson Mid Cap A
AWIIX16.64N/A
N/A
CIBC Atlas Income Opportunities Instl
ESCGX13.21N/A
N/A
Ashmore Emerging Markets Equity ESG C